Safety evaluation of the trastuzumab biosimilar in Iranian women with HER2-positive breast cancer undergoing adjuvant chemotherapy: a post-marketing surveillance.

Autor: Zahedi F; Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran., Jafari A; Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Nasiri Motlagh B; Department of Radio-Oncology, Shahid Madani Hospital, Tabriz, Iran., Hamedi SH; Radiation Oncology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Salek R; Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Khandoozi S; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Farshchian N; Imam Reza Hospital, Kermanshah University of Medicine Sciences, Kermanshah, Iran., Shahidsales S; Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Mafi AR; Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Hosseini S; Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Amouheidari A; Department of Radiation Oncology, Isfahan Milad Hospital, Isfahan, Iran., Varshoee Tabrizi F; Radiotherapy and Oncology Department, Reza Radiotherapy and Oncology Center, Mashhad, Iran., Khanjani N; Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Ahmadloo N; Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Dayyani M; Radiotherapy and Oncology Department, Reza Radiotherapy and Oncology Center, Mashhad, Iran., Khodabakhshi R; Radiation Oncology Department, Fayazbakhsh Hospital, Tehran, Iran., Mojahed MM; Valiasr Oncology Department, Qom University of Medical Sciences, Qom, Iran., Keshvari M; Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Fazl Ersi M; Radiotherapy and Oncology Department, Reza Radiotherapy and Oncology Center, Mashhad, Iran., Mirsadraee M; Radiotherapy and Oncology Department, Reza Radiotherapy and Oncology Center, Mashhad, Iran., Izadpanahi P; Radiotherapy and Oncology Department, Reza Radiotherapy and Oncology Center, Mashhad, Iran., Saadipoor A; Department of Radiation Oncology, Erfanniyayesh Hospital, Tehran, Iran., Nasrollahi H; Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Anbiaee R; Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Emadi Torghabeh A; Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Keramati A; Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran., Amiran SA; Department of Internal Medicine, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran., Bayat Mokhtari N; Radiotherapy and Oncology Department, Reza Radiotherapy and Oncology Center, Mashhad, Iran., Taghizadeh Kermani A; Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Anvari K; Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Sadeghi Ivari M; Radiotherapy and Oncology Department, Reza Radiotherapy and Oncology Center, Mashhad, Iran., Dayani M; Department of Radiation Oncology, Imam Reza Hospital of Kermanshah, Kermanshah, Iran., Amirabadi A; Innovative Medical Research Center, Faculty of Medicine, Islamic Azad University Mashhad Branch, Mashhad, Iran., Saeidi Saedi H; Associated Professor of Radiation Oncology, Guilan University of Medical Sciences, Guilan, Iran., Sabzvari A; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran., Kafi H; Medical Department, Orchid Pharmed Company, Tehran, Iran., Homaei Shandiz F; Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Publikováno v: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Aug 01, pp. 1-6. Date of Electronic Publication: 2024 Aug 01.